Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Braskem (BAK) Research & Development (2016 - 2025)

Braskem has reported Research & Development over the past 16 years, most recently at -$21.5 million for Q1 2025.

  • For Q1 2025, Research & Development changed N/A year-over-year to -$21.5 million; the TTM value through Mar 2025 reached $864716.9, changed N/A, while the annual FY2025 figure was $85.3 million, 7.1% up from the prior year.
  • Research & Development for Q1 2025 was -$21.5 million at Braskem, up from -$77.4 million in the prior quarter.
  • Over five years, Research & Development peaked at $119.6 million in Q4 2022 and troughed at -$77.4 million in Q4 2023.
  • A 4-year average of $17.9 million and a median of -$19.9 million in 2022 define the central range for Research & Development.
  • Biggest five-year swings in Research & Development: skyrocketed 34.79% in 2022 and later plummeted 164.67% in 2023.
  • Year by year, Research & Development stood at $88.7 million in 2021, then surged by 34.79% to $119.6 million in 2022, then crashed by 164.67% to -$77.4 million in 2023, then surged by 72.21% to -$21.5 million in 2025.
  • Business Quant data shows Research & Development for BAK at -$21.5 million in Q1 2025, -$77.4 million in Q4 2023, and $119.6 million in Q4 2022.